Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong
· Delayed Price · Currency is HKD 31.92
+0.26 (0.82%)
At close: Feb 27, 2026
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 3.11B CNY in the half year ending June 30, 2025, with 93.85% growth. This brings the company's revenue in the last twelve months to 6.11B, up 37.05% year-over-year. In the year 2024, Giant Biogene Holding had annual revenue of 5.54B with 57.17% growth.
Revenue (ttm)
6.11B CNY
Revenue Growth
+37.05%
P/S Ratio
5.06
Revenue / Employee
2.83M CNY
Employees
2,162
Market Cap
33.89B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hengan International Group Company | 24.81B |
| Mao Geping Cosmetics | 4.93B |
| Shanghai Chicmax Cosmetic | 8.11B |
| Blue Moon Group Holdings | 8.46B |
| Butong Group | 1.53B |
| Shanghai Forest Cabin Cosmetics Group | 1.90B |
| Cheerwin Group | 2.09B |
| Eternal Beauty Holdings | 2.24B |
Giant Biogene Holding News
- 9 months ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga